An indirect treatment comparison of efficacy and health-related quality of life following treatment with idecabtagene vicleucel versus belantamab mafodotin in triple-class exposed relapsed/refractory patients with multiple myeloma.

Rodríguez Otero, Paula; Towle, Kevin; Cope, Shannon; Caisip, Clyde; Davies, Faith E; Delforge, Michel; Weisel, Katja; Marshall, Thomas S; Karampampa, Korinna; Ayers, Dieter; Mojebi, Ali; Braverman, Julia; Farrell, James; Dhanda, Devender

Rodríguez Otero, Paula; Towle, Kevin; Cope, Shannon; Caisip, Clyde; Davies, Faith E; Delforge, Michel; Weisel, Katja; Marshall, Thomas S; Karampampa, Korinna; Ayers, Dieter; Mojebi, Ali; Braverman, Julia; Farrell, James; Dhanda, Devender.

Affiliation

Rodríguez Otero P; Clínica Universidad de Navarra, Pamplona, Spain.
Towle K; Evidence Synthesis & Decision Modeling, PRECISIONheor, Vancouver, Canada.
Cope S; Evidence Synthesis & Decision Modeling, PRECISIONheor, Vancouver, Canada.
Caisip C; Evidence Synthesis & Decision Modeling, PRECISIONheor, Vancouver, Canada.
Davies FE; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.
Delforge M; Department of Haematology, University Hospital Leuven, Leuven, Belgium.
Weisel K; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center of Hamburg-Eppendorf, Hamburg, Germany.
Marshall TS; Bristol Myers Squibb, Princeton, NJ, USA.
Karampampa K; Bristol Myers Squibb, Uxbridge, UK.
Ayers D; Evidence Synthesis & Decision Modeling, PRECISIONheor, Vancouver, Canada.
Mojebi A; Evidence Synthesis & Decision Modeling, PRECISIONheor, Vancouver, Canada.
Braverman J; Bristol Myers Squibb, Princeton, NJ, USA.
Farrell J; Bristol Myers Squibb, Dublin, Ireland.
Dhanda D; Bristol Myers Squibb, Princeton, NJ, USA.

Leuk Lymphoma ; 64(11): 1864-1869, 2023.

Article de En | MEDLINE | ID: mdl-37497883

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Myélome multiple Aspects: Patient_preference Limites: Humans Langue: En Journal: Leuk Lymphoma Sujet du journal: HEMATOLOGIA / NEOPLASIAS Année: 2023 Type de document: Article Pays d'affiliation: Espagne

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google